Figure 3 Kaplan-Meier survival curve analysis of the prognostic significance of MRTO4 with different expression in HCC. (A) Kaplan-Meier estimates of the overall survival probability of TCGA patients in HCC patients. (B) Kaplan-Meier estimates of the disease-specific survival. (C) Kaplan-Meier estimates of the progression-free interval. (D–T) Subgroup analysis for pathologic T1 stage (D), pathologic T2 stage (E), pathologic T3 stage (F), pathologic Stage I (G), pathologic Stage II (H), pathologic Stage III (I), histologic G2 grade (J), histologic G3 grade (K), male (L), Female (M), age ≤60 years old (N), age >60 years old (O), AFP >400 ng/ml (P), patients without vascular invasion (Q), patients with vascular invasion (R), Albumin <3.5 g/dl (S), prothrombin time >4 (T). * P<0.05, ** P<0.01, *** P<0.001.